IL-15/IL-15Rα Heterodimeric Complex as Cancer Immunotherapy in Murine Breast Cancer Models
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL-15/IL-15Rα Heterodimeric Complex as Cancer Immunotherapy in Murine Breast Cancer Models
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-09
DOI
10.3389/fimmu.2020.614667
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-15 in the Combination Immunotherapy of Cancer
- (2020) Thomas A. Waldmann et al. Frontiers in Immunology
- Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy
- (2019) Karin M. Knudson et al. Journal for ImmunoTherapy of Cancer
- Development of a recombinant human IL-15·sIL-15Rα/Fc superagonist with improved half-life and its antitumor activity alone or in combination with PD-1 blockade in mouse model
- (2019) Meiqi Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- IL-15 by continuous i.v. infusion to adult patients with solid tumors in a Phase I trial induced dramatic NK cell subset expansion
- (2019) Kevin C Conlon et al. CLINICAL CANCER RESEARCH
- Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model
- (2019) Alexandra Berger et al. Journal for ImmunoTherapy of Cancer
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Checkpoint Inhibitors in the Treatment of Breast Cancer
- (2018) Tomas G. Lyons et al. Current Oncology Reports
- Immune Checkpoint Inhibitor Therapy in Breast Cancer
- (2018) Cesar A. Santa-Maria et al. Journal of the National Comprehensive Cancer Network
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nano-pulse stimulation induces potent immune responses, eradicating local breast cancer while reducing distant metastases
- (2017) Siqi Guo et al. INTERNATIONAL JOURNAL OF CANCER
- IL-12 Influence mTOR to Modulate CD8+ T Cells Differentiation through T-bet and Eomesodermin in Response to Invasive Pulmonary Aspergillosis
- (2017) Hao Wang et al. International Journal of Medical Sciences
- IL-15 receptor alpha as the magic wand to boost the success of IL-15 antitumor therapies: The upswing of IL-15 transpresentation
- (2017) Johan MJ Van den Bergh et al. PHARMACOLOGY & THERAPEUTICS
- Transcription Factor T-bet Orchestrates Lineage Development and Function in the Immune System
- (2017) Axel Kallies et al. TRENDS IN IMMUNOLOGY
- Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment
- (2017) Azharuddin Sajid Syed Khaja et al. Oncotarget
- CD215+ Myeloid Cells Respond to Interleukin 15 Stimulation and Promote Tumor Progression
- (2017) Shouheng Lin et al. Frontiers in Immunology
- IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas
- (2016) Peter S. Kim et al. Oncotarget
- T-box Transcription Factors Combine with the Cytokines TGF-β and IL-15 to Control Tissue-Resident Memory T Cell Fate
- (2015) Laura K. Mackay et al. IMMUNITY
- Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
- (2015) Kevin C. Conlon et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Pathways: Interleukin-15 Signaling in Health and in Cancer
- (2014) A. Mishra et al. CLINICAL CANCER RESEARCH
- Preassociation of IL-15 with IL-15R -IgG1-Fc Enhances Its Activity on Proliferation of NK and CD8+/CD44high T Cells and Its Antitumor Action
- (2014) S. Dubois et al. JOURNAL OF IMMUNOLOGY
- IL-15.IL-15R complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells
- (2014) F. Tamzalit et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Electrotransfer of single-stranded or double-stranded DNA induces complete regression of palpable B16.F10 mouse melanomas
- (2013) L Heller et al. CANCER GENE THERAPY
- Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer
- (2013) Cristina Iclozan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Characterization and Favorablein VivoProperties of Heterodimeric Soluble IL-15·IL-15Rα Cytokine Compared to IL-15 Monomer
- (2013) Elena Chertova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
- (2012) Minu K. Srivastava et al. PLoS One
- CpG and Interleukin-15 Synergize to Enhance IFN-γ Production by Activated CD8+T Cells
- (2012) Dustin Cobb et al. Biomed Research International
- IL-15 administered by continuous infusion to rhesus macaques induces massive expansion of CD8+ T effector memory population in peripheral blood
- (2011) M. C. Sneller et al. BLOOD
- Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells
- (2009) Moses K. Donkor et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- IL-15 Renders Conventional Lymphocytes Resistant to Suppressive Functions of Regulatory T Cells through Activation of the Phosphatidylinositol 3-Kinase Pathway
- (2009) M. B. Ahmed et al. JOURNAL OF IMMUNOLOGY
- Imagable 4T1 model for the study of late stage breast cancer
- (2008) Kai Tao et al. BMC CANCER
- Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis
- (2008) Mehran Habibi et al. BREAST CANCER RESEARCH AND TREATMENT
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Interleukin-15/Interleukin-15R Complexes Promote Destruction of Established Tumors by Reviving Tumor-Resident CD8+ T Cells
- (2008) M. Epardaud et al. CANCER RESEARCH
- The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells
- (2008) Thomas Y. Wuest et al. JOURNAL OF LEUKOCYTE BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started